GlassScriptPhysician profile
Kalpesh Mistry
NPI 1740717669
$1,699.50
in general payments reported to CMS, 2019-2025
24 companies · $541 in 2025
The $541 reported for 2025 was more than what 75% of Family Medicine providers received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $147 · 2020: $18.59 · 2021: $119 · 2022: $44.99 · 2023: $506 · 2024: $324 · 2025: $541.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,371.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,370.52 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Next Science LLC | $353.54 | 2023-2024 | Blastx, Xperience, Surgx |
| Smith+Nephew, INC. | $344.78 | 2023-2025 | Collagenase Santyl, Renasys Touch, Renasys Go V2 Home |
| Mimedx Group, INC. | $176.87 | 2025 | |
| Organogenesis INC. | $127.98 | 2021-2025 | Apligraf |
| Astellas Pharma US INC | $100.00 | 2019 | |
| Melinta Therapeutics, LLC | $62.75 | 2021-2022 | |
| Ets Wound Care LLC | $52.74 | 2025 | Mirragen Advanced Wound Matrix |
| Polymedics Innovations INC. | $51.98 | 2023 | |
| Reprise Biomedical, INC. | $49.27 | 2024-2025 | Miro3d, Miro 3d |
| Boston Scientific Corporation | $48.50 | 2023-2024 | Wavewriter Alpha Prime 16 |
| Solventum Corporation | $41.07 | 2024-2025 | Activ.A.C., Promogran Prisma, V.A.C. Dermatac |
| Tactile Systems Technology INC | $40.85 | 2025 | Nimbl, Flexitouch Plus |
| Nuo Therapeutics | $33.07 | 2023 | |
| Reapplix INC. | $32.74 | 2022-2023 | 3c Patch Kit - Box |
| Progenacare Global, LLC | $24.59 | 2024 |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Kerecis Limited | $22.70 | 2024 | Kerecis Omega3 Marigen, Kerecis Omega3 Surgiclose |
| Medline Industries LP | $20.59 | 2024 | Medline, Medline Industries, INC. |
| Hydrofera LLC | $20.27 | 2025 | Hydrofera Blue |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $18.59 | 2020 | |
| Medtronic Vascular, INC. | $17.31 | 2019 | |
| Mallinckrodt Enterprises LLC | $16.01 | 2019 | |
| Aroa Biosurgery Incorporated | $15.35 | 2024 | |
| Genentech USA, INC. | $14.76 | 2021 | |
| Lilly USA, LLC | $13.19 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kalpesh Mistry listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.